Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
04/15 16:29 (美东)
Mineralys Therapeutics | EFFECT:其他
04/12 06:07 (美东)
Mineralys Therapeutics | 424B5:募资说明书
04/11 16:42 (美东)
Mineralys Therapeutics | ARS:年度报告
04/09 07:24 (美东)
Mineralys Therapeutics | DEFA14A:其他
04/09 07:20 (美东)
Mineralys Therapeutics | DEF 14A:股东委托书决议
04/09 07:19 (美东)
Mineralys Therapeutics | 8-K:重大事件
04/04 08:05 (美东)
Mineralys Therapeutics | S-3/A:特定交易注册声明(修正)
03/29 16:48 (美东)
Mineralys Therapeutics | 8-K:Mineralys Therapeutics公布2023年第四季度和全年财务业绩并提供公司最新情况
03/21 07:46 (美东)
Mineralys Therapeutics | S-3:特定交易注册声明
03/21 07:36 (美东)
Mineralys Therapeutics | 10-K:年度报表
03/21 07:21 (美东)
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
03/13 17:40 (美东)
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
02/15 16:28 (美东)
Mineralys Therapeutics | 4:持股变动声明-高管 Levy Adam Scott
02/15 16:28 (美东)
Mineralys Therapeutics | 4:持股变动声明-高管 Congleton Jon
02/15 16:28 (美东)
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等
02/15 16:23 (美东)
Mineralys Therapeutics | 4:持股变动声明-董事 AKKARAJU SRINIVAS
02/14 21:08 (美东)
Mineralys Therapeutics | 4:持股变动声明-股东 Samsara BioCapital GP, LLC
02/14 21:08 (美东)
Mineralys Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
02/14 19:53 (美东)
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%)等
02/14 06:07 (美东)
暂无数据
暂无数据